those readings that provide clinically useful information. One of these is the indeterminate cytology reading. The risk of malignancy in patients whose FNABC specimens are indeterminate is reported to be anywhere from 14-42% [9] [10] [11] [12] [13] [14] [15] . Follicular thyroid adenoma (FTA) and follicular thyroid cancer (FTC) can give indeterminate readings on FNABC. Recently, some studies have shown that molecular analysis of thyroid nodules can be applied in a clinical setting and can improve the accuracy of the diagnosis [16] [17] [18] [19] [20] [21] [22] [23] . However, none of the methods has been fully validated to the extent that it is in general use in the routine diagnostic laboratory. On the other hand, advance in the resolving power of ultrasonography (US) apparatus have provided more information not only concerning the location of thyroid nodules, but also features that are associated with benign nodules and features associated with malignant nodules [24] [25] [26] [27] [28] [29] . Papillary thyroid carcinoma (PTC) can now be identified with reasonably high accuracy not only by Between January 2007 and December 2008, 3333 patients underwent thyroidectomy at our institution. The 737 patients who did not have a diagnosis of malignancy by FNABC and US before thyroidectomy were the subjects of this study. None of these patients had previous thyroid surgery or had a history of neck irradiation. There were 585 females and 152 males. Their median age was 51 years (range: 12 to 82 years old). The final diagnosis was made by postoperative histopathological examination of the surgical specimens, and concomitant incidental micropapillary carcinomas were excluded from the final diagnosis.
Total thyroidectomy was performed for patients with multinodular goiter diagnosed as hyperplastic nodule preoperatively. Hemithyroidectomy was performed if the nodule was classified as indeterminate by FNABC, and completion total thyroidectomy was performed if postoperative histology showed malignancy. The study was reviewed and approved by the Institution's Ethics Board and performed in accordance with the Declaration of Helsinki.
Ultrasonographic evaluation
The ultrasound scanners used were HDI 5000 7-15-MHz linear probe (Philips Medical Systems, Bothell, Wash. USA), LOGIQ 9 7-15-MHz linear probe (GE Medical Systems, Milwaukee, WI USA), Voulson 730 (GE Medical Systems), and Voulson E8 (GE Medical Systems). US examination was made by sonographers who had trained for at least 6 months in the ultrasonography center of our institution, and the evaluation and diagnosis were made by the attending endocrinologists and endocrine surgeons according to the ultrasound findings and the diagnostic criteria that are used in our institution (Table 1 ). The US features of the thyroid nodules were evaluated according to size, shape, margin, echogenicity, calcification, and internal color flow. Internal echo flow was defined as centripetal flow seen within the nodule. The US diagnoses of thyroid nodules were classified into 3 categories, hyperplastic nodule (HN), follicular tumor (FT), and Cancer. In the US diagnosis categories, HN means adenomatous nodule (goiter), FT means follicular adenoma or follicular carcinoma, and Cancer means papillary carcinoma or anaplastic carcinoma. All the patients in this study had been diagnosed with HN or FT based on the US findings.
Fine needle aspiration biopsy cytology
Endocrinologists and endocrine surgeons who had its features on cytology, but also by its US features. In contrast, at least as far as FTC is concerned, it is difficult to differentiate FTC from FTA by these modalities. Several papers have reported characteristic sonographic features of FTC [30] [31] [32] [33] . However, US is currently not considered an accepted method for the diagnosis of FTC and its role to allow clinicians to assess the likelihood that a thyroid nodule is FTC, as compared to FTA, is uncertain. Distant metastases are more common in FTC than in PTC and the prognosis is poorer. Preoperative tests to assess the likelihood of FTC in thyroid nodules, and thus reduce surgical procedures that are likely to be unnecessary, are very much needed. The purpose of this study is to know how accurately US and FNABC can diagnose FTC before thyroidectomy and we retrospectively studied patients with thyroid nodules that had been characterized by US and FNABC as "apparently not malignant" before thyroidectomy.
subjects and Methods

Patients
At our institution, patients with thyroid nodules routinely have US of the nodules and thyroid function and related tests including serum triglyceride (Tg), anti-Tg antibodies (TgAb), and anti-thyroid peroxidase antibodies (TPOAb), all US at their first visit. When nodules are not entirely cystic according to the US images, FNABC is performed under US guidance. Preoperative tests that we consider indicative of malignancy are cytology readings, "malignant" or "suspicious for malignancy", or US readings, "cancer." The indications for thyroid surgery at our institution for patients in whom these tests are not indicative of malignancy are a goiter of approximately more than 5 cm in diameter, goiter that extends into the mediastinum, symptoms due to compression by a goiter, and indeterminate cytology and/or a diagnosis of a follicular tumor based on the US findings ( Table  1) . We treat patients with a preoperative diagnosis of follicular tumor or FTA surgically because FTC is difficult to distinguish from FTA preoperatively, and because minimally invasive FTC does not always have favorable prognosis [34] . Patients who did not have thyroid surgery were followed in our outpatient clinic at 6 to 12 month intervals. US was routinely performed at every follow-up visit and FNABC was performed when a follicular tumor or cancer was suspected on the basis of the US findings or when the nodule increased in size.
results
Histological diagnosis and patients' characteristics
The postoperative histopathological diagnosis was HN in 416 patients, FTA in 200 patients, FTC in 99 patients (minimally invasive FTC in 82, widely invasive FTC in 17), and other thyroid disease in 22 patients, including PTC in 13 (ordinary in 8, follicular variant in 4, macrofollicular variant in 1), medullary thyroid carcinoma in 2, hyalinizing trabecular tumor in 3, Hashimoto thyroiditis in 2, and metastatic malignant tumor from another organ in 2 (one from renal cell carcinoma, and the other from a sarcoma of unknown origin). There were 116 patients (15.7%) who had a malignant thyroid nodules and the proportion of these patients who had FTC and PTC was 85.3% and 11.2%, respectively.
The characteristics of the patients are shown in Table 2 . There were no significant differences in gender or age distribution related to the histopathological diagnosis. The median size of the nodules evaluated by preoperative US was 50 mm (range: 10 mm to 160 mm). The size of nodule of patients with HN was significantly larger than in the patients with FTA and FTC, and the size of nodules in patients with FTA was significantly larger than in patients with FTC. Patients with FTC had significantly higher preoperative Tg levels than patients with HN.
Preoperative US diagnosis and histopathological findings
The US diagnosis was HN in 582 patients (79%) and FT in 155 (21%) patients. The final histopathological diagnosis was malignant disease in 67 (11.5%) of the 582 patients with preoperative diagnosis of HN trained for 6 months in the ultrasonography center of our institution performed real-time US-guided FNABC of thyroid nodules. When the US image was read as multinodular goiter, FNABC was performed on several solid nodules. Local anesthesia was not routinely administered before performing FNABC. FNABC was performed with a 22-gauge needle attached to a 20mL disposable syringe and an aspirator under US guidance with a 12 MHz digital linear transducer. If the US image was read as solid nodule, aspiration of the sample was made usually from the peripheral and central part of the nodule. Aspirated samples of the nodules were expelled onto a glass slide and then immediately placed in 95% alcohol for Papanicolaou staining. Two cytopathologists who specialized in thyroid cytology and 6 registered cytotechnologists (member of the International Academy of Cytology) interpreted the FNABC findings. The cytology reports in our institution are placed into one of five categories: malignant, suspicious for malignancy, indeterminate, benign, or inadequate. The FNABC results of all of the patients in this study were classified into 2 categories, benign or indeterminate. The "benign" mainly considered of hyperplastic nodule (hyperplastic nodule), Graves' disease, and lymphocytic thyroiditis and the "indeterminate" category mainly considered of follicular or Hürthle cell neoplasm.
Statistical analysis
We used the chi-squared test or Fisher exact test to perform the statistical analyses, and statistical significance was assigned when the p value was <0.05. The calculations were made with a statistical software program (JMP 8.0, SAS Institute, Inc., Cary, NC). 
ses based on the histopathological diagnosis is presented in Table 5 . Of the 505 patients with a preoperative diagnosis of "benign" by FNABC, the nodule was malignant in 42 patients (8.3%), 34 of whom had FTC (6.7%). Of the 232 patients with a preoperative diagnosis of "indeterminate" by FNABC, the nodule was malignant in 74 (31.9%), 65 (28%) of whom had FTC. Patients with widely invasive FTC were observed in 5 (1%) of patients with FNABC diagnosis of benign, and 12 (5.2%) of patients with FNABC diagnosis of indeterminate.
Combination of US and FNABC diagnosis and histopathological findings
The rates of thyroid malignancy and FTC in patients with 4 categories based on US and FNABC readings are shown in Table 6 . Malignant tumor were diagnosed in 5.7 % of the patients who had HN in US reading and benign in FNABC reading and in 36.4% of the patients who had FT in US readings and indeterminate in by US, and of these patients there were 56 (9.6%) with FTC. Of the 155 patients with a diagnosis of FT by US the final diagnosis was malignant in 49 (31.6%), 43 (27.7%) of whom had FTC (Table 3) . Patients with widely invasive FTC were observed in 7 (1.2%) of patients with US diagnosis of HN, and 10 (6.5%) of patients with US diagnosis of FT.
The histopathological diagnoses for US findings of multinodularity and cystic change are presented in Table 4 . Both multinodularity (HN vs. FTA p=0.001, HN vs. FTC p=0.005) and cystic change (HN vs. FTA p<0.0001, HN vs. FTC p< 0.0001) were significantly more frequent in the patients with hyperplastic nodule than in the patients with FTA and FTC. However, the frequency of multinodularity and cystic change were similar in patients with FTC and FTA.
FNABC diagnosis and histopathological findings
The accuracy of the preoperative FNABC diagno- 
discussion
FNABC has been main diagnostic tool because it is safe, accurate, and simple. The use of FNABC has resulted in a decrease in the number of benign nod-FNABC reading. FTC was diagnosed in 34.1% of the patients who had FT in US readings and indeterminate in FNABC reading, 4.8% of the patients who had HN in US reading and benign in FNABC reading, and in approximately 20% of patients with either FT in US reading and indeterminate in FNABC reading. When the nodule was examined only by FNABC, FTC was diagnosed in 34 of 505 patients with benign in FNABC reading (6.7%). On the other hand, when combined As a result of improvements in technology US is now being used to characterize distinct features in the images of thyroid nodules. The US features of thyroid nodules have been studied, and predictive malignant features were reported [24] [25] [26] [27] [28] [29] . The US features of follicular tumor, including of follicular carcinomas and follicular adenomas, have been reported to be: isoechoic/hypoechoic echotexture, predominantly solid and homogenous, well defined halo, and central internal color flow [30] [31] [32] [33] . However, we think that the role of US in diagnosing follicular tumors lies in differentiating follicular tumors from hyperplastic nodules, not in differentiating follicular carcinomas from adenomas.
A comprehensive diagnostic strategy appears be necessary to manage follicular tumor and, we demonstrated that US and FNABC played complementary role in diagnosing follicular carcinoma. Of 438 patients who were concurrently diagnosed as having a benign nodule by FNABC and having HN by US, 21 (4.8%) were diagnosed with FTC after thyroidectomy, and only 1 (0.2%) of them was diagnosed with widely invasive FTC. The result of this study demonstrated that follicular carcinoma can be rather correctly diagnosed by both modalities. The adequacy of our surgical indication is supported by the fact that the patients with follicular carcinoma, especially the patients with widely invasive follicular carcinoma, underwent surgery within a significantly shorter interval after the diagnosis was made than the patients with hyperplastic nodule. However, this study has potential limitation because it was retrospective study and there was inevitable bias in patient selection. Not all patients with thyroid nodules have indications for surgery and most of patients with thyroid nodules are followed up without surgical treatment.
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ule surgeries and an increase in the cancer detection rate. There have been many reports on the diagnostic accuracy of FNABC [35, 36] . Preoperative diagnosis of FTC has been major clinical problem for many years because FTC is diagnosed not by cellular atypia, but by structural atypia. It is difficult to differentiate from follicular adenoma or even from hyperplastic nodule. FTC comprises about 10% of all malignant nodules and may be sometimes overlooked because the diagnosis is usually made after thyroidectomy and based on histopathological findings. However, distant metastases occasionally occur in patients with FTC and the prognosis depends on the occurrence of distant metastases. Although the number of cases of follicular carcinoma has been reported to be decreasing, a diagnostic system that will lead to a reduction in the number of unnecessary surgical procedures for thyroid nodules and not to miss the diagnosis of follicular carcinoma needs to be established. Recently, a number of promising molecular and immunohistochemical methods have been described, which could improve the diagnostic accuracy of fine-needle aspiration biopsy [16] [17] [18] [19] [20] [21] [22] [23] . However, there is some inter-laboratory variability in the sensitivity and specificities obtained with the individual techniques [37] . Significantly, none of the methods has been fully validated to the extent that it is in general use in the routine diagnostic laboratory.
Actually indication for thyroidectomy depends on FNABC. Several FNABC reporting systems have been proposed and an effort should always be made to diagnose follicular carcinoma more accurately [38, 39] . In this study, 65 (28%) of the patients with indeterminate cytology had FTC, a rate that was much higher than those from previous reports [9] [10] [11] [12] [13] [14] [15] . Recent studies have reported a higher prevalence of papillary carcinoma or follicular variant papillary carcinoma than follicular carcinoma in thyroid nodules diagnosed as indeterminate by FNABC [10] [11] [12] [13] [14] . This higher prevalence of follicular carcinoma is thought to be due to our surgical indication and this may be due to our surgical strategy, that follicular tumor including FTA should be treated surgically. On the other hand, of the 505 patients with benign cytology in our study, 34 (6.7%) were diagnosed with FTC histopathologically. The high rate of malignancy among the patients with benign cytology in our study is thought to be due to the fact that the surgical indications used at our institution are based on the US findings as well as FNABC findings.
